Pdac
Entity.
- Evidence
- 37 documents · 15 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 8 Apr 2026, last seen 2 Oct 2026
- Measured
- 8% of mentions say something specific about it; the rest only name it
- As of
- 6 Oct 2026
Where this comes from
- Cancer Res · 2026-10-02 · Targeting Distinct Cell Cycle Nodes Overcomes RAS Inhibitor Resistance. (opens the source in a new tab)
- Inside Precision Medicine · 2026-10-01 · Oncolytic Virus May Boost First-in-Line Chemotherapy for Metastatic PDAC (opens the source in a new tab)
- GEN - Genetic Engineering & Biotechnology News · 2026-09-30 · Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue (opens the source in a new tab)
- Expert Opin Biol Ther · 2026-09-28 · Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer. (opens the source in a new tab)
- Frontiers Precision Oncology · 2026-09-25 · Individualized treatment of HER2-positive breast cancer patients with lung metastasis using a circulating tumor cell drug sensitivity test: a case report (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-25 · Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-25 · ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer (opens the source in a new tab)
- Inside Precision Medicine · 2026-09-24 · New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer (opens the source in a new tab)
- GEN - Genetic Engineering & Biotechnology News · 2026-09-24 · Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models (opens the source in a new tab)
- Oncologist · 2026-09-23 · Current Landscape of RAS-Targeted Therapy for Pancreatic Cancer. (opens the source in a new tab)
- Proc Natl Acad Sci U S A · 2026-09-22 · IRE1α-XBP1s signaling links lipid homeostasis to hypoxic maladaptation and KRAS inhibitor responses in pancreatic ductal adenocarcinoma. (opens the source in a new tab)
- KRAS Mutation Research (Google News) via Google News · 2026-09-17 · Phase 1 Data Support DAWN-303’s Evaluation of INCB161734 in Frontline KRAS G12D–Mutated PDAC - OncLive (no link on file)